W
William J. Feuer
Researcher at University of Miami
Publications - 420
Citations - 24814
William J. Feuer is an academic researcher from University of Miami. The author has contributed to research in topics: Visual acuity & Glaucoma. The author has an hindex of 80, co-authored 403 publications receiving 21870 citations. Previous affiliations of William J. Feuer include Bascom Palmer Eye Institute & Washington University in St. Louis.
Papers
More filters
Journal ArticleDOI
An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration.
Anne E. Fung,Geeta A. Lalwani,Philip J. Rosenfeld,Sander R. Dubovy,Stephan Michels,William J. Feuer,Carmen A. Puliafito,Janet L. Davis,Harry W. Flynn,Maria Esquiabro +9 more
TL;DR: In this paper, an optical coherence tomography (OCT)-guided, variable-dosing regimen with intravitreal ranibizumab for the treatment of patients with age-related macular degeneration (AMD) was evaluated.
Journal ArticleDOI
A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study.
Geeta A. Lalwani,Philip J. Rosenfeld,Anne E. Fung,Sander R. Dubovy,Stephen Michels,William J. Feuer,Janet L. Davis,Harry W. Flynn,Maria Esquiabro +8 more
TL;DR: The PrONTO Study using an OCT-guided variable-dosing regimen with intravitreal ranibizumab resulted in VA outcomes comparable with the outcomes from the phase III clinical studies, but fewer intravItreal injections were required.
Journal ArticleDOI
Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years
Samuel G. Jacobson,Artur V. Cideciyan,R. Ratnakaram,Elise Héon,Sharon B. Schwartz,Alejandro J. Roman,Marc C. Peden,Tomas S. Aleman,Sanford L. Boye,Alexander Sumaroka,Thomas J. Conlon,Roberto Calcedo,Jijing Pang,Kirsten E. Erger,Melani B. Olivares,Cristina L. Mullins,Malgorzata Swider,Shalesh Kaushal,William J. Feuer,Alessandro Iannaccone,Gerald A. Fishman,Edwin M. Stone,Barry J. Byrne,William W. Hauswirth +23 more
TL;DR: Gene therapy for Leber congenital amaurosis caused by RPE65 mutations is sufficiently safe and substantially efficacious in the extrafoveal retina and the results point to specific treatment strategies for subsequent phases.
Journal ArticleDOI
Evaluation of Subjective Assessments and Objective Diagnostic Tests for Diagnosing Tear-Film Disorders Known to Cause Ocular Irritation
Stephen C. Pflugfelder,Scheffer C.G. Tseng,Olga Sanabria,Hans Kell,Carlos G. Garcia,Carlos Felix,William J. Feuer,Brenda L. Reis +7 more
TL;DR: Which subjective assessments and objective tests have clinical utility as diagnostic tools in ocular irritation associated with Sjögren's syndrome—related aqueous tear deficiency, non-Sj Ögren ATD, inflammatory meibomian gland disease (MGD) associated with rosacea, and atrophic MGD are determined.
Journal ArticleDOI
Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.
Ryan M. Rich,Philip J. Rosenfeld,Carmen A. Puliafito,Sander R. Dubovy,Janet L. Davis,Harry W. Flynn,Serafin Gonzalez,William J. Feuer,Richard C. Lin,Geeta A. Lalwani,Jackie K. Nguyen,Gaurav Kumar +11 more
TL;DR: Off-label intravitreal bevacizumab therapy for neovascular ARMD was well tolerated over 3 months with improvements in visual acuity and OCT central retinal thickness measurements.